Tumor cells and blood clots in veins
Part of Cancer, Heart & circulation clinical trials.
This study looks at the link between tumor cells found in the blood and blood clots in the veins. It is for people who have had or will have a procedure to remove a blood clot, whether they have cancer or not.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You either have no cancer (and haven't had any in the past 5 years) or you have been diagnosed with a malignant tumor.
- You have had a procedure to remove a blood clot from a vein using a catheter (a thin tube), or you are willing to have this procedure.
- You are not currently in shock or have a severe infection (sepsis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to best treat blood clots in veins near the skin in people who also have active cancer. It will compare different treatment options to find what works best and is safest for you.
This study follows people who have both cancer and a blood clot. It aims to learn more about how these clots happen and how they are treated in cancer patients, so doctors can improve care.
This study is a registry that collects information about blood clot events in people with cancer. The goal is to better understand how often clots happen and what patterns they follow, which can help improve care.
This study looks at how well blood thinners (anticoagulants) work in people with cancer who have had a blood clot. It aims to compare the benefits and risks of different anticoagulant medicines.
This trial checks whether a blood test that looks at tumor cells can help guide treatment for people with breast cancer. If you join, your care team will follow your responses over time to see if this “phenotype surveillance” approach is useful.
This trial studies how your blood's ability to clot changes over time in people with certain cancers who have not yet started treatment. The goal is to better predict who might develop a dangerous blood clot, so that preventative steps can be taken.
Hear when a new Tumor Cells, Circulating trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.